Jade Biosciences prices $150M public offering of common stock at $15
· seekingalpha.com
Jade Biosciences (JBIO) plans a $150M stock offering at $15/share, closing June 5, 2026, to fund trials, R&D and manufacturing—read the details now.
Jade Biosciences (JBIO) has announced the pricing of a public offering of 10M shares of its common stock, priced at $15.00 per share, expected to raise gross pr...